Arca biopharma Announces Activation Of First Canadian Genetic-AF Clinical Trial Site
December 11, 2014 at 08:32 AM EST
ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, ...